PolicyBrief
H.R. 3239
119th CongressMay 7th 2025
Research Advancing to Market Production for Innovators Act
IN COMMITTEE

The Research Advancing to Market Production for Innovators Act streamlines federal small business research funding by prioritizing commercial viability, accelerating review timelines, increasing technical assistance flexibility, and establishing dedicated officials and impact assessments to boost technology transition from lab to market.

Chrissy Houlahan
D

Chrissy Houlahan

Representative

PA-6

LEGISLATION

New Bill Speeds Up Federal R&D Grants, Adds $50K for Commercialization Support, and Prioritizes Patents

The aptly named Research Advancing to Market Production for Innovators Act is essentially a major overhaul of the government’s flagship programs for funding small business research—the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. It aims to fix the notoriously slow pace of federal bureaucracy and ensure that taxpayer-funded research actually leaves the lab and hits the market. Think of this as the government trying to make its R&D process faster, smarter, and much more focused on making money.

The Need for Speed and Market Smarts

If you’re a small business trying to get a federal grant, time is literally money. This bill cuts down the time limit for certain procedural reviews in the SBIR/STTR process from a potential one year down to 180 days. That’s huge for startups operating on tight budgets. More importantly, it changes how proposals are judged. Review panels must now include at least one expert in commercialization. This means that alongside checking the scientific rigor, they’ll be asking the crucial question: “Can this idea actually be sold?” This new focus on market viability, laid out in Section 2, means fewer grants for great science that can’t find a customer, and more funding for innovations with a clear path to production.

Dedicated Guides and Flexible Cash for Growth

To ensure these innovations don’t get lost in the federal pipeline, Section 4 mandates that every agency running an SBIR/STTR program must appoint a Technology Commercialization Official. This isn't just a new title; this official must have real-world experience in bringing products to market. Their job is to coach awardees, help them find non-SBIR/STTR government contracts (Phase III), and generally guide them out of the research phase. For the small business owner, this means having an experienced guide inside the agency to help navigate the tricky transition from prototype to product.

Furthermore, the bill significantly boosts the technical and business assistance (TABA) funding available. Under Section 5, Phase I awardees can now access up to $6,500 per project, and Phase II awardees get a massive jump to $50,000 per project for TABA services. Crucially, this assistance now explicitly includes cybersecurity assistance, a necessity in today’s digital economy. Small businesses can use this money flexibly—they can hire new staff, train existing employees, or pay for external vendors, giving them the resources they need to actually scale up.

Training and Protection for Innovators

Section 6 ensures that recipients can use their award money to participate in an Innovation Corps (I-Corps) teams course, a popular program that teaches researchers how to find their market and pivot their business strategy. This is like getting a mini-MBA focused specifically on commercializing your federally funded tech. And because innovation means nothing without protection, Section 8 requires the Small Business Administration to partner with the U.S. Patent and Trademark Office (USPTO) to create a special, prioritized patent examination program just for SBIR/STTR recipients. For a startup, shaving months off the patent process can mean the difference between securing market share and being outpaced by a competitor.

The Accountability Check

While the bill is designed to help innovators, it also adds a layer of accountability. Section 7 requires the SBA to produce an annual “commercialization impact assessment.” This report will track the financial success of companies that receive a high volume of Phase II awards (50 or more over nine years). They’ll track everything from gross revenue and non-SBIR federal contracts to patents and even mergers. This means the government is finally measuring the actual return on investment for its most successful research grants, making sure these programs are creating lasting economic value, not just cool science projects.